CC BY-NC-ND
0J Ginseng Res 38 (2014) 47-51
Contents lists available at ScienceDirect
Journal of Ginseng Research
journal homepage: http://www.ginsengres.com
Research article
Evaluation of glucosidases of Aspergillus niger strain comparing with other glucosidases in transformation of ginsenoside Rb1 to ginsenosides Rg3
Kyung Hoon Chang1, Mi Na Jo1, Kee-Tae Kim2, Hyun-Dong Paik
1 Department of Food Science and Biotechnology of Animal Resources, Konkuk University, Seoul, Korea
2 Bio/Molecular Informatics Center, Konkuk University, Seoul, Korea
1,2, *
ARTICLE INFO
Article history: Received 23 July 2013 Received in Revised form 10 September 2013 Accepted 10 September 2013
Keywords: Aspergillus niger b-glucosidase ginsenoside Rg3 Panax ginseng transformation
ABSTRACT
The transformation of ginsenoside Rb1 into a specific minor ginsenoside using Aspergillus niger KCCM 11239, as well as the identification of the transformed products and the pathway via thin layer chromatography and high performance liquid chromatography were evaluated to develop a new biologically active material. The conversion of ginsenoside Rb1 generated Rd, Rg3, Rh2, and compound K although the reaction rates were low due to the low concentration. In enzymatic conversion, all of the ginsenoside Rb1 was converted to ginsenoside Rd and ginsenoside Rg3 after 24 h of incubation. The crude enzyme (b-glucosidase) from A. niger KCCM 11239 hydrolyzed the b-(1 /6)-glucosidic linkage at the C-20 of ginsenoside Rb1 to generate ginsenoside Rd and ginsenoside Rg3. Our experimental demonstration showing that A. niger KCCM 11239 produces the ginsenoside-hydrolyzing b-glucosidase reflects the feasibility of developing a specific bioconversion process to obtain active minor ginsenosides.
Copyright © 2013, The Korean Society of Ginseng, Published by Elsevier. All rights reserved.
1. Introduction
Ginseng, the root of Panax ginseng Meyer, is one of the most popular traditional herbal medicines. It has been used for thousands of years in Asian countries, and has also recently become popular in Western countries. Ginseng harbors a variety of bioac-tive compounds, including ginsenosides (ginseng saponins), acidic polysaccharides, phenolics, and polyacetylenes [1]. Among these, the ginsenosides have been well characterized for their functionality, and are thus regarded as the principal components responsible for the pharmacological and biological activities of ginseng [2].
Ginsenosides are composed of a dammarane backbone with several side chains, including glucose, arabinose, xylose, and rhamnose side chains [3]. Thus far, more than 50 types of ginsenosides have been isolated and identified from Panax ginseng Meyer [4]. Based on the differences in their chemical constitutions, the ginsenosides are generally classified into three types: proto-panaxadiol (PPD), protopanaxatriol, and olenolic acid. Among those thus far identified, six major ginsenosides (Rb1, Rb2, Rc, Rd, Re, and Rg1) have been determined to account for 90% of the total ginsenoside content of P. ginseng Meyer [5]. In particular, ginsenoside
Rbl is present in greater abundance (usually >20% of total ginsenosides) than any other ginsenosides in P. ginseng, Panax quinque-folius, Panax japonicum and Panax notoginseng [6]. Earlier reports have shown that the major PPD-type ginsenosides (Rbl, Rb2, Rc, Rd) are metabolized by intestinal bacteria after oral administration to minor ginsenosides such as Rg3, Rh2, F2, and compound K (CK) [7]. In recent years, it has been demonstrated that the minor ginsenosides possess remarkable pharmaceutical activity and can be readily absorbed by the human body [8]. For example, ginsenoside Rg3 induces tumor cell apoptosis, inhibits tumor cell proliferation and attenuates tumor invasion and metastasis [9,10]. In addition, Rg3 serves as a natural cytoprotective agent against environmental carcinogens [11]. Therefore, a variety of studies have focused on the conversion of major ginsenosides to the more active minor ginse-nosides via methods such as heating [12], acid treatment [13], alkali treatment [14], and enzymatic conversion [15,16]. Chemical transformation induces side reactions including epimerization, hydrox-ylation, and hydration, and also generates more environmental pollution [17]. By contrast, microbial or enzymatic approaches have arisen as the predominant conversion modalities, owing to their marked selectivity, mild reaction conditions, and environmental compatibility.
* Corresponding author. Division of Animal Life Science, Konkuk University, Seoul 143-701, Korea. E-mail address: hdpaik@konkuk.ac.kr (H.-D. Paik).
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
1226-8453/$ — see front matter Copyright © 2013, The Korean Society of Ginseng, Published by Elsevier. All rights reserved. http://dx.doi.org/10.1016/j.jgr.2013.11.008
Some studies have involved attempts to find suitable microbes or enzymes that can transform Rbl into minor ginsenosides such as Rd, F2, Rg3, and compound K [4,17—20]. However, the majority of the microorganisms employed in these experiments are not of food-grade.
Aspergillus niger strain has been known to be one of the most popular fungi in fermentation of the crops such as soybean and in brewing industry due to its production of various hydrolyzing exoenzymes [21]. In particular, production of glucosidase by using A. niger as a good producer has been recently studied by many researchers [22]. Therefore, in this study, we focused narrowly on the transformation of ginsenoside Rbl into specific minor ginse-nosides using A. niger, which has been generally regarded as safe by the Food and Drug Administration.
2. Materials and methods
2.1. Materials
Ginsenosides Rbl, Rd, 20(S)-Rg3, 20(R)-Rg3, Rh2, and CK were purchased from Vitrosys, Inc. (Yeongju, Korea). Ginsenoside Rbl, Rd, 20(S)-Rg3, and 20(R)-Rg3. p-Nitrophenyl-P-D-glucopyranoside (PNPG), p-nitrophenol (PNP), and P-glucosidase from almond were purchased from Sigma-Aldrich (St Louis, MO, USA). Potato dextrose broth was purchased from Difco (Miller, Becton Dickinson, and Co., Sparks, MD, USA). Celluclast 1.5L and Cellulase 12T were purchased from Novozymes (Bagsvsrd, Denmark) and Bioland Co. (Chung-nam, Korea), respectively. High performance liquid chromatography (HPLC; Agilent 1100 series; Agilent Technologies, Palo Alto, CA, USA) was conducted using a UV/vis detector and a gradient pump. All solvents used in chromatography were of HPLC grade and all other chemicals were of analytical reagent grade.
2.2. Growth and crude enzyme production
A. niger KCCM 11239 was purchased from the Korean Culture Center of Microorganisms (KCCM, Seoul, Korea). The fungus was cultured on potato dextrose agar at 30° C for 4 d, and the stock cultures were maintained at 4°C. Erlenmeyer flasks were filled to 20% of their volume with potato dextrose broth, and subsequently inoculated with 5-d cultures. The cultures were grown for 16 d under shaking conditions at 200 rpm at 30° C. During the shake flask culturing, a few glass beads were added to prevent mycelial clumping and thus to achieve homogeneous growth. After incubation, the culture broth was centrifuged at 9,000 x g at 4°C for 10 min, and a crude enzyme was obtained by precipitation with 70% of (NH4)2SO4 of the supernatant. The specific activity of crude enzyme was detected to 91 U/mg.
2.3. Assay of enzyme activity
Beta-glucosidase activity was evaluated via a colorimetric method using PNPG as a substrate. The reaction mixture, which contained 1 mL of 5 mM PNPG and 100 mL of enzyme solution, was incubated at 50° C for 10 min. The reaction was subsequently terminated via the addition of 1 mL of 0.5 M NaOH, and the absorption of the released PNP was measured at 400 nm. One unit of P-glucosidase activity was defined as the quantity of enzyme required to liberate 1 mM of PNP/min under standard conditions [23].
2.4. Biotransformation of ginsenoside Rbl
Microbial transformation was conducted via a modified Cheng's method [24]. In brief, suspensions of the 5 d-old cultures were mixed with an equal volume of 1 mM ginsenoside Rb1 dissolved in 0.5 M sodium phosphate buffer (pH 5.5) and were shaken for 16 d,
200 rpm, at 30°C. Enzymatic transformation was conducted with 200 mL of a 16-d culture supernatant (centrifuged at 14,400 x g for 30 min at 4° C) and the same volume of 1 mM ginsenoside Rb1 was reacted for 48 h at 30° C and 50° C. Aliquots were withdrawn at suitable time intervals (0.5 h, 1 h, 2 h, 4 h, 8 h, 12 h, and 24 h). To compare of ginsenosides produced by commercial P-glucosidase, a 200 mL of each enzyme solution (approximately 200 U) was added into a reaction mixture and samples were picked for thin layer chromatography (TLC) after 48 h.
2.5. Extraction of crude saponin
The reaction mixtures were extracted twice with 200 mL of water-saturated n-butanol. The n-butanol fraction was evaporated to generate the crude saponin fraction with a rotary vacuum evaporator (N-1000V, EYELA, Tokyo, Japan). Crude saponin was dissolved in 50 mL of methanol, which was subjected to TLC and HPLC determination. The samples were then passed through a 0.45 mm PTFE syringe filter (Whatman, Brentford, Middlesex, UK) prior to injection.
2.6. TLC and HPLC analysis for determination of ginsenosides
TLC was conducted on silica gel 60F254 plates. A solvent mixture of chloroform:methanol:water (65:35:10 v/v/v, lower phase) was used as the developing solvent. The spots were detected by spraying with 10% sulfuric acid followed by heating under a lamp flame until the spots became clearly visible. Ginsenosides and transformed ginsenosides were identified and assayed via comparison with known ginsenoside standards.
HPLC was conducted using an Agilent 1100 system (Agilent Technologies) at a detection wavelength of 203 nm. The column used was a reverse-phase column (C18, 4.6 mm x 150 mm, 5 mm) and an injection volume of sample was 20 mL. The mobile phase utilized gradient conditions with solvents A (CH3CN:H2O = 100:0) and B (CH3CN:H2O = 14:86). The solvent A and B ratios were as follows: [20% A (0 min)]; 20% A (5 min); 30% A (10 min); 30% A (15 min); 60% A (20 min); 60% A (23 min); 0% A (25 min)] with a 1.2 mL/min flow rate.
2.7. Statistical analysis
Each experiment was individually repeated three times. All data were assigned for purposes of comparison and an analysis of variance (ANOVA) was carried out by using SPSS version 8.0 (SPSS Inc., Chicago, IL, USA). A p-value of <0.05 was considered significant.
3. Results
3.1. Microbial conversion of ginsenoside Rbl during culturing
Aspergillus species are known as a useful source of P-glucosidase and A. niger is by far the most efficient P-glucosidase producer among the microorganisms investigated thus far. Changes in the growth and P-glucosidase activity of A. niger KCCM 11239 on potato dextrose broth medium at 30° C were evaluated under aerobic conditions (data not shown). Very little P-glucosidase was detected in the culture broth until 12 d, but then the activity dramatically increased and reached to a maximum level (197.7 U/mL) after approximately 16 d. After that time, it appeared that the activity was slightly decreased by protease existing in culture broth. From the results, it is presumed that a production pattern of P-glucosi-dase is nongrowth associated type.
S 2 4 6 8 10 12 14 16 S Reaction time (d)
Fig. 1. TLC analysis of the time-course transformation of ginsenoside Rbl by Aspergillus niger KCCM 11239. Suspensions of the 5-d cultures were mixed with an equal volume of 1 mM ginsenoside Rbl. S is the mixture of ginsenoside standards; TLC, thin layer chromatography.
The microbial conversion of ginsenoside Rbl was prepared by inoculating ginsenoside Rbl into precultured suspensions, followed by 16 d of incubation of the mixture at 30° C and 200 rpm. The microbial conversion was checked via TLC at 2-d intervals. During the 2-d growth period, much of the enzyme seemed to be produced, as evidenced by the observation of increased ginsenoside Rg3 levels. Fig. 1 shows that most of the ginsenoside Rb1 was converted to ginsenoside Rg3 and generated less polar metabolites after 4 d of incubation. Indeed, after 10 d, A. niger produced a less polar metabolite, with an Rf value similar to that of ginsenoside Rh2 and compound K. This result suggests that the microbial conversion of ginsenoside Rb1 using A. niger KCCM 11239 induced the production of diverse PPD-type ginsenosides. We estimated that this result was induced by different types of ß-glucosidase from A. niger KCCM 11239.
Aspergillus species are known to produce different types of ß-glucosidase. For example, Aspergillus sp. g48p produces two types of ginsenoside-hydrolyzing ß-glucosidases: ginsenosidase type II
hydrolyzes 20-0-glycosides of PPD-type ginsenosides and ginsenosidase type I hydrolyzes 3-0 and 20-0 glycosides of PPD-type ginsenosides [25].
3.2. Enzymatic conversion of ginsenoside Rbl
The enzymatic conversion of ginsenoside Rb1 over a time-course was conducted using a crude enzyme. Ginsenoside Rb1 was reacted with the same volume of crude enzyme for 48 h at 30° C and 50° C; the TLC results are shown in Fig. 2. When ginsenoside Rb1 was reacted at 30° C, the levels of ginsenoside Rd were increased within 30 min and the levels of ginsenoside Rg3 were increased after 4 h. All of the ginsenoside Rb1 was converted to ginsenoside Rd and ginsenoside Rg3 after 24 h of incubation. Ginsenoside Rb1 was reacted with crude enzyme at 50° C to compare the effects of the reaction temperature. The results demonstrate that high reaction temperatures accelerate the reaction to produce ginsenoside Rg3. In addition, the conversion activity of A. niger after 48 h of a reaction time were compared by using three commercial enzymes (Fig. 3). When ginsenoside Rb1 was reacted with Celluclast 1.5Land Cellulase 12T, the content of ginsenoside Rb1 was reduced and a productivity of Rd increased after 48 h. However, these enzymes were not converted further into active minor ginsenosides Rg3. In case of ß-glucosidase from almond, ginsenoside hydrolyzing activity was not detected.
3.3. HPLC assay of metabolites
Various products of Rb1 transformed by the crude enzyme isolated from A. niger KCCM 11239 were confirmed via HPLC analysis. The profile of the reaction mixture of ginsenoside Rb1 at 30°C for 24 h of reaction is shown in Fig. 4. HPLC analysis yielded results similar to the findings of TLC. In addition, the amount of ginsenoside Rb1 was reduced with the extension of the reaction time, whereas other hydrolysis products including ginsenoside Rd and S-Rg3 increased after 24 h of incubation at 30° C. Ginsenoside Rb1 harbors four ß-glucosidic linkages, including a 20-C, ß-(1 /6) and a 3-C, ß-(1/2) linkage. Fig. 4 shows that a peak area of Rd in a sample increased after 8 h, but decreased after 24 h. In the meantime, ginsenoside Rg3 was detected in a 24 h-reaction mixture and a ratio of the peak area was approximately 48.5%. By contrast, ginsenoside Rb1 was not detected in a 24-h reaction mixture. These
S 0.5 1 2 4 8 12 24 S S 0.5 1 2 4 8 12 24 S
Reaction time (h) Reaction time (h)
Fig. 2. TLC analysis of time-course transformation of ginsenoside Rb1 by the crude enzyme from Aspergillus niger KCCM 11239. Crude enzyme was mixed with an equal volume of 1 mM ginsenoside Rb1 and then reacted for 24 h at (A) 30°C and (B) 50°C. S is the mixture of ginsenoside standards; TLC, thin layer chromatography.
Fig. 3. Comparison of ginsenoside Rb1 transformation activity using commercial enzymes. S, ginsenoside standards; 1, crude enzyme from Aspergillus niger KCCM 11239; 2, Celluclast 1.5L; 3, Cellulase 12-T; 4, b-glucosidase from almond.
results show that ginsenoside Rb1 can be converted to ginsenoside Rd by the loss of a glucose moiety at the b-(1 /6)-glucosidic linkage of the C-20 position of the ginsenoside aglycon [26]. Finally, ginsenoside Rg3 can also be produced from ginsenoside Rd via the additional hydrolysis of a glucose moiety. In production of ginse-noside Rg3, a peak area ratio of ginsenoside 20(S)-Rg3:20(R)-Rg3 isomer was calculated to be approximately 83:17. There have been
previous reports on microbial sources capable of converting the major ginsenoside Rb1 to ginsenoside Rg3. Microbacterium sp. GS514 exhibited a marked ability to convert ginsenoside Rb1 to Rg3 [4]. The enzymes isolated from the strain GS514 hydrolyzed the terminal glucose and then the inner glucose at position C-20. Ginsenosidase type II from Aspergillus sp. g48p hydrolyzed PPD ginsenosides such as Rb1, Rb2, Rc, or Rb3 to generate Rd, and also slowly hydrolyzes the 20-O-glucoside of Rd to produce a very small quantity of ginsenoside Rg3 [25].
It was reported that ginsenoside Rd as an intermediate has a variety of pharmaceutical activities, including the prevention of kidney injury by chemical drugs [27], the prevention of the concentration of blood vessels [28], enhancement of the differentiation of neural stem cells [29]. In addition, it has been shown that ginsenoside Rg3, in particular the S form Rg3, prevents endothelial cell apoptosis via the Akt-dependent inhibition of the mitochondria [10], and regulates voltage-dependent Ca2+, Na+, and K+ channel activity [30].
In conclusion, it has been shown that ginseng has various bio-functional effects including ginsenosides and their derivatives. Ginsenoside Rb1 is present in greater abundance than any other ginsenosides in the root, but ginsenoside Rg3 has greater biological effects for human health though its content is relatively very low in ginseng. We can transform from Rb1 to Rg3 by using enzymatic hydrolysis for a larger production. The pathway of enzymatic hydrolysis of Rb1 to produce Rb3 has already been shown by Chang et al [31]. A production yield of minor ginsenoside such as Rg3 depends on many kinds of glucosidase. In this study, hydrolysis of Rb1 by b-glucosidase produced from the A. niger strain was evaluated comparing with a commercial enzyme such as Celluclast 1.5L, Cellulase 12T, and other b-glucosidase (from almond) for higher
Hil. .____ (__Uw'L—___
!{ k A A _
Rbl Rd S-Rg3 F2 R-Rg3 CK
Time (min)
Fig. 4. Time-course HPLC analysis of metabolites of ginsenoside Rb1 converted by the crude enzyme from Aspergillus niger KCCM 11239. The crude enzyme was mixed with an equal volume of 1 mM ginsenoside Rb1 and reacted for 24 h at 30°C. HPLC, high performance liquid chromatography; S is the mixture of ginsenoside standards.
yields of Rg3. From these results, it appeared that P-glucosidase produced from A. niger strain had a greater hydrolytic activity on Rb1 than any other glucosidase tested in this study. Actually, a crude enzyme of this study has various glucosidase [25], and it is thought that hydrolysis of Rb1 is done by a combination of these glucosidases. As further research, we will examine the mechanism of hydrolysis with combined enzymes of crude samples. These compounds can be used for the development of new pharmaceutical materials such as antiturmeric agents and this is a valuable technique for bioconversion for new compounds in the pharmaceutical industry.
Conflicts of interest
All contributing authors declare no conflicts of interest.
Acknowledgments
This research was supported by Technology Development Program (Grant No. 610002-03-02-SB220) through the Ministry for Food, Agriculture, Forestry and Fisheries, and by the Priority Research Centers Program (Grant No. 2009-0093824) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology, Republic of Korea.
References
[1] Baque MA, Moh SH, Lee EJ, Zhong JJ, Paek KY. Production of biomass and useful compounds from adventitious roots of high-value added medicinal plants using bioreactor. Biotechnol Adv 2012;30:1255-67.
[2] Han S, Kim JS, Jung BK, Han SE, Nam JH, Kwon YK, Nah SY, Kim BJ. Effects of ginsenoside on pacemaker potentials of cultured interstitial cells of Cajal clusters from the small intestine of mice. Mol Cells 2012;33:243-9.
[3] Shibata S, Ando T, Tanaka O. Chemical Studies on the Oriental Plant Drugs. XVII. The prosapogenin of the ginseng saponins: ginsenosides-Rb1,-Rb2, and -Rc. Chem Pharm Bull (Tokyo) 1966;14:1157-61.
[4] Cheng LQ, Na JR, Bang MH, Kim MK, Yang DC. Conversion of major ginsenoside Rb1 to 20(S)-ginsenoside Rg3 by Microbacterium sp. GS514. Phytochemistry 2008;69:218-24.
[5] Li WK, Gu CG, Zhang HJ, Awang DVC, Fitzloff JF, Fong HHS, Van Breeman RB. Use of high performance liquid chromatography tandem mass spectrometry to distinguish Panax ginseng C.A. Meyer (Asian ginseng) and Panax quinque-folius. L. (American ginseng). Anal Chem 2000;72:5417-22.
[6] Ji QC, Harkey MR, Henderson GL, Gershwin ME, Stem JS, Hackman RM. Quantitative determination of ginsenosides by high-performance liquid chromatography-tandem mass spectrometry. Phytochem Anal 2001;12: 320-6.
[7] Akao T, Kanaoka M, Kobashi K. Appearance of compound K, a major metabolite of ginsenoside Rb1 by intestinal bacterial in rat plasma after oral administration-measurement of compound K by enzyme immunoassay. Biol Pharm Bull 1998;21:245-9.
[8] Paek IB, Moon Y, Kim J, Ji HY, Kim SA, Sohn DH, Kim JB, Lee HS. Pharmaco-kinetics of a ginseng saponin metabolite compound K in rats. Biopharm Drug Dispos 2006;27:39-45.
[9] Liu WK, Xu SX, Che CT. Anti-proliferative effect of ginseng saponins on human prostate cancer cell line. Life Sci 2000;67:1297-306.
10] Min JK, Kim JH, Cho YL, Maeng YS, Lee SJ, Pyun BJ, Kim YM, Park JH, Kwon YG. 20(S)-Ginsenoside Rg3 prevents endothelial cell apoptosis via inhibition of a mitochondrial caspase pathway. Biochem Biophys Res Commun 2006;349: 987-94.
11] Poon PY, Kwok HH, Yue PY, Yang MS, Mak NK, Wong CK, Wong RN. Cyto-protective effect of 20(S)-Rg3 on benzo[a]pyrene-induced DNA damage. Drug Metab Dispos 2012;40:120-9.
12] Kim WY, Kim JM, Han SB, Lee SK, Kim ND, Park MK, Kim CK, Park JH. Steaming of ginseng at high temperature enhances biological activity. J Nat Prod 2000;63:1702-4.
13] Han BH, Park MH, Han YN, Woo WS, Sankawa U, Yahara S, Tanaka O. Degradation of ginseng saponins under mild acidic condition. Planta Med 1982;44:146-9.
14] Yang L, He KJ, Yang Y. A preparation method of less polar individual ginse-nosides and saponins by base hydrolysis; 2003. China Patent CN03134090.3.
15] Luan H, Liu X, Qi X, Hu Y, Hao D, Cui Y, Yang L. Purification and characterization of a novel stable ginsenoside Rb1-hydrolyzing ß-D-glucosidase from China white jade snail. Process Biochem 2006;41:1974-80.
16] Qin Y, Zhou X, Zhou W, Li X, Feng M, Zhou P. Purification and properties of a novel beta-glucosidase, hydrolyzing ginsenoside Rb1 to CK, from Paecilomyces bainier.J Microbiol Biotechn 2008;18:1081-9.
17] Zhao X, Wang J, Li J, Fu L, Gao J, Du X, Bi H, Zhou Y, Tai G. Highly selective biotransformation of ginsenoside Rb1 to Rd by the phytopathogenic fungus Cladosporium fulvum (syn. Fulvia fulva). Microbiol Biotechnol 2009;36:721-6.
18] Gao J, Zhao X, Liu H, Fan Y, Cheng H, Liang F, Chen X, Wang N, Zhou Y, Tai G. A highly selective ginsenoside Rb1-hydrolyzing ß-d-glucosidase from Cladosporium fulvum. Process Biochem 2010;45:897-903.
19] Kim MY, Lee JW, Lee KY, Yang DC. Microbial conversion of major ginsenoside Rb1 to pharmaceutically active minor ginsenoside Rd. J Microbiol 2005;43: 456-62.
20] Noh KH, Son JW, Kim HJ, Oh DK. Ginsenoside compound K production from ginseng root extract by a thermostable ß-glycosidase from Sulfolobus sol-fataricus. Biosci Biotechnol Biochem 2009;73:316-21.
21] Lv XC, Huang ZQ, Zhang W, Rao PF, Ni L. Identification and characterization of filamentous fungi isolated from fermentation starters for Hong Qu glutinous rice wine brewing. J Gen Appl Microbiol 2012;58:33-42.
22] Pederson L, Hansen K, Nielsen J, Lantz AE, Thykaer J. Industrial glucoamylase fed-batch benefits from oxygen limitation and high osmolarity. Biotechnol Bioeng 2012;109:116-24.
23] Kohchi C, Toh-e A. Cloning of Candida pelliculosa ß-glucosidase gene and its expression in Saccharomyces cerevisiae. Mol Gen Genet 1986;203:89-94.
24] Cheng LQ, Kim M, Lee JW, Lee YJ, Yang DC. Conversion of major ginsenoside Rb1 to ginsenoside F2 by Caulobacter leidyia. Biotechnol Lett 2006;28: 1121-7.
25] Yu H, Liu Q, Zhang C, Lu M, Fu Y, Im YT, Lee ST, Jin F. A new ginsenosidase from Aspergillus strain hydrolyzing 20-0-multi-glycoside of PPD ginsenoside. Process Biochem 2009;44:772-5.
26] Quan LH, Min JW, Yang DU, Kim YJ, Yang DC. Enzymatic biotransformation of ginsenoside Rb1 to 20(S)-Rg3 by recombinant beta-glucosidase from Micro-bacterium esteraromaticum. Appl Microbiol Biot 2012;94:377-84.
27] Lee JK, Choi SS, Lee HK, Han KJ, Han EJ, Suh HW. Effects of ginsenoside Rd and decursinol on the neurotoxic responses induced by kainic acid in mice. Planta Med 2003;69:230-4.
28] Zeng S, Guan YY, Liu DY, He H, Wang W, Qiu QY, Wang XR, Wang YD. Synthesis of 12-epi-ginsenoside Rd and its effects on contractions of rat aortic rings. Chin Pharmacol Bull 2003;19:282-6.
29] Shi Q, Hao Q, Bouissac J, Lu Y, Tian S, Luu B. Ginsenoside-Rd from Panax notoginseng enhances astrocyte differentiation from neural stem cells. Life Sci 2005;76:983-5.
30] Jeong SM, Lee JH, Kim JH, Lee BH, Yoon IS, Lee JH, Kim DH, Rhim H, Kim Y, Nah SY. Stereospecificity of ginsenoside Rg3 action on ion channels. Mol Cells 2004;18:383-9.
31] Chang KH, Jo MN, Kim KT, Paik HD. Purification and characterization of a ginsenoside Rb1-hydrolyzing ß-glucosidase from Aspergillus niger KCCM 11239. Int J Mol Sci 2012;13:12140-52.
